The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
C-Reactive Protein, a Sensitive Marker of Inflammation, Predicts Future Risk of Coronary Heart Disease in Initially Healthy Middle-Aged Men: Results From the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992
Open accessAbstract
Background —Inflammatory reactions in coronary plaques play an important role in the pathogenesis of acute atherothrombotic events; inflammation elsewhere is also associated with both atherogenesis generally and its thrombotic complications. Recent studies indicate that systemic markers of inflammation can identify subjects at high risk of coronary events. Methods and Results —We used a sensitive immunoradiometric assay to examine the association of serum C-reactive protein (CRP) with the incidence of first major coronary heart disease (CHD) event in 936 men 45 to 64 years of age. The subjects, who were sampled at random from the general population, participated in the first MONICA Augsburg survey (1984 to 1985) and were followed for 8 years. There was a positive and statistically significant unadjusted relationship, which was linear on the log-hazards scale, between CRP values and the incidence of CHD events (n=53). The hazard rate ratio (HRR) of CHD events associated with a 1-SD increase in log-CRP level was 1.67 (95% CI, 1.29 to 2.17). After adjustment for age, the HRR was 1.60 (95% CI, 1.23 to 2.08). Adjusting further for smoking behavior, the only variable selected from a variety of potential confounders by a forward stepping process with a 5% change in the relative risk of CRP as the selection criterion, yielded an HRR of 1.50 (95% CI, 1.14 to 1.97). Conclusions —These results confirm the prognostic relevance of CRP, a sensitive systemic marker of inflammation, to the risk of CHD in a large, randomly selected cohort of initially healthy middle-aged men. They suggest that low-grade inflammation is involved in pathogenesis of atherosclerosis, especially its thrombo-occlusive complications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,630
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Baumann, H., & Gauldie, J. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90137-6 · Cited by 2,899
The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina
Liuzzo, G., Biasucci, L. M., Gallimore, J. R., Grillo, R. L., Rebuzzi, A. G., Pepys, M. B., & Maseri, A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408183310701 · Cited by 2,357
Self-citationTunstall-Pedoe, H., Kuulasmaa, K., Amouyel, P., Arveiler, D., Rajakangas, A. M., & Pajak, A. (1994) · Circulation · doi:10.1161/01.cir.90.1.583 · Cited by 2,263
Modeling and variable selection in epidemiologic analysis
Greenland, S. (1989) · American Journal of Public Health · doi:10.2105/ajph.79.3.340 · Cited by 2,208
van der Wal, A. C., Becker, A. E., van der Loos, C. M., & Das, P. K. (1994) · Circulation · doi:10.1161/01.cir.89.1.36 · Cited by 1,910
Thompson, S. G., Kienast, J., Pyke, S. D. M., Haverkate, F., & van de Loo, J. C. W. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503093321003 · Cited by 1,821
WHO MONICA Project Principal Invest (1988) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(88)90084-4 · Cited by 1,794
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-499_7 · Cited by 1,564
Production of C-reactive protein and risk of coronary events in stable and unstable angina
Haverkate, E., Thompson, S. G., Pyke, S. D., Gallimore, J. R., & Group, M. B. P. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07591-5 · Cited by 1,500
Periodontal Disease and Cardiovascular Disease
Beck, J., Garcia, R., Heiss, G., Vokonas, P. S., & Offenbachet, S. (1996) · Journal of Periodontology · doi:10.1902/jop.1996.67.10.1123 · Cited by 1,458
The mortality of rheumatoid arthritis
Wolfe, F., Mitchell, D. M., Sibley, J. T., Fries, J. F., Bloch, D. A., Williams, C. A., Spitz, P. W., Haga, M., Kleinheksel, S. M., & Cathey, M. A. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780370408 · Cited by 1,310
Kornitzer, M., Berghmans, L., Wilmet, M. D., Darquennes, H., Lagasse, R., & Payen, R. (1988) · Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) · Cited by 1,270
Chronic infections and coronary heart disease: is there a link?
Danesh, J., Collins, R., & Peto, R. (1997) · The Lancet · doi:10.1016/s0140-6736(97)03079-1 · Cited by 1,211
Relation of C-Reactive Protein and Coronary Heart Disease in the MRFIT Nested Case-Control Study
for the MRFIT Research Group, Kuller, L. H., Tracy, R. P., Shaten, J., & Meilahn, E. N. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008963 · Cited by 1,097
Mendall, M. A., Patel, P., Ballam, L., Strachan, D., & Northfield, T. C. (1996) · BMJ · doi:10.1136/bmj.312.7038.1061 · Cited by 846
C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor
Cermak, J., Key, N., Bach, R., Balla, J., Jacob, H., & Vercellotti, G. (1993) · Blood · doi:10.1182/blood.v82.2.513.513 · Cited by 839
Tracy, R. P., Lemaitre, R. N., Psaty, B. M., Ives, D. G., Evans, R. W., Cushman, M., Meilahn, E. N., & Kuller, L. H. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.6.1121 · Cited by 836
Macy, E. M., Hayes, T. E., & Tracy, R. P. (1997) · Clinical Chemistry · doi:10.1093/clinchem/43.1.52 · Cited by 797
Prineas, R. J., Crow, R. S., & BLACKBURN, H. W. (1982) · Cited by 701
Vigushin, D. M., Pepys, M. B., & Hawkins, P. N. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116336 · Cited by 636
Self-citationTissue Factor Modulates the Thrombogenicity of Human Atherosclerotic Plaques
Toschi, V., Gallo, R., Lettino, M., Fallon, J. T., Gertz, S. D., Ferna´ndez-Ortiz, A., Chesebro, J. H., Badimon, L., Nemerson, Y., Fuster, V., et al. (1997) · Circulation · doi:10.1161/01.cir.95.3.594 · Cited by 603
Elevation of C-reactive protein in “active” coronary artery disease
Berk, B. C., Weintraub, W. S., & Alexander, R. W. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)90079-g · Cited by 588
Torzewski, J., Torzewski, M., Bowyer, D. E., Fröhlich, M., Koenig, W., Waltenberger, J., Fitzsimmons, C., & Hombach, V. (1998) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.18.9.1386 · Cited by 561
Self-citationJuhan-Vague, I., Pyke, S. D. M., Alessi, M. C., Jespersen, J., Haverkate, F., & Thompson, S. G. (1996) · Circulation · doi:10.1161/01.cir.94.9.2057 · Cited by 552
Leukocytes and the Risk of Ischemic Diseases
Ernst, E. (1987) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1987.03390170074031 · Cited by 541
WHO Expert Committee on Biological Standardization.
Horowitz, B., Minor, P., Jj, M., Burnouf, T., McIntosh, R., Padilla, A., Thorpe, R., & van Aken, W. G. (1994) · PubMed · Cited by 534
Definition, measurement, and classification of the syndromes of obesity.
Ga, B. (1978) · PubMed · Cited by 342
COMPLEMENT ACTIVATION BY C‐REACTIVE PROTEIN COMPLEXES*
Volanakis, J. E. (1982) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1982.tb22140.x · Cited by 278
Fibrin and Fibrinogen-Related Antigens in Patients with Stable and Unstable Coronary Artery Disease
Kruskal, J. B., Commerford, P. J., Franks, J. J., & Kirsch, R. E. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711263172201 · Cited by 265
Symptoms of chronic bronchitis and the risk of coronary disease
Jousilahti, P., Vartiainen, E., Tuomilehto, J., & Puska, P. (1996) · The Lancet · doi:10.1016/s0140-6736(96)02374-4 · Cited by 244
Tissue-factor antigen and activity in human coronary atherosclerotic plaques
Ardissino, D., Merlini, P. A., Ariëns, R., Coppola, R., Bramucci, E., & Mannucci, P. M. (1997) · The Lancet · doi:10.1016/s0140-6736(96)11189-2 · Cited by 228
Spodick, D. H., Flessas, A. P., & Johnson, M. M. (1984) · The American Journal of Cardiology · doi:10.1016/0002-9149(84)90016-x · Cited by 205
Expression of C-reactive protein by alveolar macrophages
Dong, Q., & Wright, J. R. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.12.4815 · Cited by 193
WHO MONICA Project: Objectives and Design
WHO MONICA Project (1989) · International Journal of Epidemiology · doi:10.1093/ije/18.3_supplement_1.s29 · Cited by 172
Keil, U., Stieber, J., Döring, A., Chambless, L. E., Härtel, U., Filipiak, B. C., Hense, H. W., TIETZE, M., & Gostomzyk, J. G. (1988) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1988.tb05563.x · Cited by 144
C-reactive protein: binding to lipids and lipoproteins.
Pepys, M. B., Rowe, I. F., & Baltz, M. L. (1985) · PubMed · Cited by 137
Self-citationInteraction of C-reactive protein with artificial phosphatidylcholine bilayers and complement.
Volanakis, J. E., & Narkates, A. J. (1981) · The Journal of Immunology · doi:10.4049/jimmunol.126.5.1820 · Cited by 133
Viral and bacterial infections in patients with acute myocardial infarction
MATTILA, K. J. (1989) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1989.tb00084.x · Cited by 133
Rapid Automated High Sensitivity Enzyme Immunoassay of C-Reactive Protein
Wilkins, J., Gallimore, J. R., Moore, E. G., & Pepys, M. B. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.6.1358 · Cited by 123
Self-citationLöwel, H., Lewis, M., Hörmann, A., & Keil, U. (1991) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(91)90036-9 · Cited by 106
Köenig, W., Sund, M., Do¨ring, A., & Ernst, E. (1997) · Circulation · doi:10.1161/01.cir.95.2.335 · Cited by 103
Self-citationTissue Factor Expression on Macrophages in Coronary Plaques in Patients with Unstable Angina
Kaikita, K., Ogawa, H., Yasue, H., Takeya, M., Takahashi, K., Saito, T., Hayasaki, K., Horiuchi, K., Takizawa, A., Kamikubo, Y., et al. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.10.2232 · Cited by 103
Fibrinogen and Cardiovascular Risk
Ernst, E., & Köenig, W. (1997) · Vascular Medicine · doi:10.1177/1358863x9700200207 · Cited by 97
Hatanaka, K., Li, X., Masuda, K., et al. (1995) · Pathology International · doi:10.1111/j.1440-1827.1995.tb03515.x · Cited by 68
Sublytic complement attack exposes C-reactive protein binding sites on cell membranes.
Li, Y. P., Mold, C., & Clos, T. W. D. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.6.2995 · Cited by 53
EFFECTS OF C‐REACTIVE PROTEIN (CRP) ON PLATELET FUNCTION*
Fiedel, B. A., Simpson, R. M., & Gewurz, H. (1982) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1982.tb22142.x · Cited by 25
Cited by
Inflammation and Atherosclerosis
Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724
Pearson, T. A., Mensah, G. A., Alexander, R. W., Anderson, J. L., Cannon, R. O., Criqui, M., Fadl, Y. Y., Fortmann, S. P., Hong, Y., Myers, G. L., et al. (2003) · Circulation · doi:10.1161/01.cir.0000052939.59093.45 · Cited by 6,401
Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433
Ridker, P. M., Rifai, N., Rose, L., Buring, J. E., & Cook, N. R. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021993 · Cited by 3,604
Metadata
- Authors
- Koenig, W., Sund, M., Fröhlich, M., Fischer, H.-G., Löwel, H., Döring, A., Hutchinson, W. L., & Pepys, M. B.
- Venue
- Circulation
- Published
- 1999-01-19
- Volume
- 99
- Issue
- 2
- Pages
- 237-242
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1981851376
- Cited by
- 1,964
- References
- 49
- FWCI
- 94.71
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.